| Literature DB >> 20498850 |
Orjan de Manzano1, Simon Cervenka, Anke Karabanov, Lars Farde, Fredrik Ullén.
Abstract
Several lines of evidence support that dopaminergic neurotransmission plays a role in creative thought and behavior. Here, we investigated the relationship between creative ability and dopamine D2 receptor expression in healthy individuals, with a focus on regions where aberrations in dopaminergic function have previously been associated with psychotic symptoms and a genetic liability to schizophrenia. Scores on divergent thinking tests (Inventiveness battery, Berliner Intelligenz Struktur Test) were correlated with regional D2 receptor densities, as measured by Positron Emission Tomography, and the radioligands [(11)C]raclopride and [(11)C]FLB 457. The results show a negative correlation between divergent thinking scores and D2 density in the thalamus, also when controlling for age and general cognitive ability. Hence, the results demonstrate that the D2 receptor system, and specifically thalamic function, is important for creative performance, and may be one crucial link between creativity and psychopathology. We suggest that decreased D2 receptor densities in the thalamus lower thalamic gating thresholds, thus increasing thalamocortical information flow. In healthy individuals, who do not suffer from the detrimental effects of psychiatric disease, this may increase performance on divergent thinking tests. In combination with the cognitive functions of higher order cortical networks, this could constitute a basis for the generative and selective processes that underlie real life creativity.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20498850 PMCID: PMC2871784 DOI: 10.1371/journal.pone.0010670
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Mean values, minimum, maximum and standard deviations of all variables of interest.
| Measure | Age | BIS | ZF | AM | TN | Raven | Thalamus | Striatum | FC |
|
| 59 | 296 | 103 | 98 | 95 | 39 | 2.60 | 2.63 | 0.40 |
| Minimum | 41 | 269 | 83 | 72 | 80 | 29 | 1.86 | 2.27 | 0.21 |
| Maximum | 65 | 350 | 119 | 117 | 114 | 52 | 3.28 | 2.99 | 0.65 |
|
| 8 | 23 | 13 | 15 | 10 | 6 | 0.50 | 0.18 | 0.15 |
Age = Participant age; BIS = Berliner Intelligenz Struktur Test scores; ZF = BIS subtest figural fluency; AM = BIS subtest verbal fluency; TN = BIS subtest numerical fluency; Raven = Raven's Standard Progressive Matrices Plus scores. Thalamus = Dopamine D2 receptor binding potential (D2BP) in the thalamus; Striatum = D2BP in the striatum; FC = D2BP in the frontal cortex.
Partial correlations between regional D2 receptor binding potential, divergent thinking and intelligence, controlling for age.
| Measure | Raven | BIS | ||
| Thalamus | .27 |
| −.64 |
|
| Striatum | .39 |
| .01 |
|
| FC | .31 |
| −.23 |
|
*Significant at p≤0.017, corrected for multiple comparisons (n = 3) using an α = 0.05.
One-tailed p-value (direction of correlation according to hypothesis). Other values are two-tailed.
Raven = Raven's Standard Progressive Matrices Plus scores; BIS = Berliner Intelligenz Struktur Test scores; Thalamus = Dopamine D2 receptor binding potential (D2BP) in the thalamus; Striatum = D2BP in the striatum; FC = D2BP in the frontal cortex.
Figure 1Correlations between divergent thinking scores and dopamine D2 binding potential.
(A) Correlation between thalamic D2 binding potential (D2BP) and divergent thinking (BIS score). (B) Correlation between D2BP and BIS score in the striatum. (C) Correlation between D2BP and BIS score in the frontal cortex.
Figure 2Regions of interest (ROI).
(A) Sagittal image of regional radioactivity after intravenous injection of [11C]FLB 457 in one subject. Thalamic ROI. (B) Coronal image of regional radioactivity after intravenous injection of [11C]raclopride. Striatal ROI.